Caption Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,152
Closed -$1.47M 1593
2025
Q4
$1.47M Sell
7,152
-148
-2% -$27.9K 0.01% 933
2025
Q3
$1.15M Sell
7,300
-8,500
-54% -$1.31M 0.01% 1058
2025
Q2
$2.65M Buy
+15,800
New +$2.34M 0.03% 630
2023
Q1
Sell
-18,400
Closed -$1.41M 1125
2022
Q4
$1.41M Buy
18,400
+17,724
+2,622% +$1.35M 0.02% 644
2022
Q3
$45K Sell
676
-25,840
-97% -$1.64M ﹤0.01% 1390
2022
Q2
$1.39M Buy
26,516
+2,516
+10% +$143K 0.02% 767
2022
Q1
$1.36M Sell
24,000
-22,500
-48% -$1.2M 0.02% 864
2021
Q4
$2.39M Buy
+46,500
New +$2.28M 0.03% 724
2021
Q3
Sell
-45,000
Closed -$2.57M 1528
2021
Q2
$2.57M Buy
+45,000
New +$2.63M 0.03% 594
2019
Q4
Sell
-12,500
Closed -$646K 837
2019
Q3
$590K Buy
+12,500
New +$571K 0.03% 468

Other funds holding CAH

Caption Management's CAH Position: Q1 2026 in Review

Caption Management sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 7,152 shares — an estimated $1.47M sold.

Caption Management first reported a position in CAH in Q3 2019 and held it in 10 quarters. The position peaked at $2.65M in Q2 2025. 1,436 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Caption Management reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 7,152 Cardinal Health shares in Q1 2026, an estimated $1.47M.
  • Caption Management first reported a position in Cardinal Health in Q3 2019 and held it in 10 quarters.
  • Caption Management's Cardinal Health position peaked at $2.65M in Q2 2025.
  • 1,436 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.